BNB Plus

BNB Plus Corp., formerly known as Applied DNA Sciences, is a biotechnology company that utilizes a dual business model to drive value through nucleic acid manufacturing and a digital asset treasury strategy. Operating primarily through its subsidiary LineaRx, the company commercializes the LineaDNA platform, which uses large-scale PCR for cell-free DNA production, and the Linea IVT platform for high-efficiency mRNA manufacturing. These proprietary technologies provide genetic medicine and diagnostic developers with high-fidelity, scalable alternatives to conventional plasmid-based production methods. Based in Stony Brook, New York, BNB Plus is publicly traded on the Nasdaq and actively manages a treasury of BNB tokens to generate yield within the Binance ecosystem.